Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial
-
Published:2024-10
Issue:
Volume:63
Page:2-12
-
ISSN:2405-4577
-
Container-title:Clinical Nutrition ESPEN
-
language:en
-
Short-container-title:Clinical Nutrition ESPEN
Author:
Li Bang-yan,
Xi Yue,
Liu Yu-Ping,
Wang Di,
Wang Cheng,
Chen Chao-gang,
Fang Xiao-hong,
Li Zhong-xia,
Chen Yu-mingORCID
Reference46 articles.
1. LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease;Lee;Exp Mol Med,2023
2. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018
3. Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy;Polyzos;Semin Cancer Biol,2023
4. Lifestyle interventions in nonalcoholic fatty liver disease;Younossi;Nat Rev Gastroenterol Hepatol,2023
5. A comprehensive systematic review of the effects of naringenin, a citrus-derived flavonoid, on risk factors for nonalcoholic fatty liver disease;Naeini;Adv Nutr,2021